This scenario serves as an example on the potential troubles physicians can encounter though dealing with sufferers which has a designer BZD overdose. Deficiency of trusted and accessible checks to detect Diclazepam and insufficient unique indicators and signs can make it difficult to discover these conditions.If this SPL has inactivated NDCs outli